Symbols / LNAI $0.37 -9.47% Lunai Bioworks Inc.
LNAI Chart
About
Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform technology for early cancer detection and its recurrence that uses a multi-omics approach to search for individual biomarkers that are present even in asymptomatic patients. The company was formerly known as Renovaro Inc. and changed its name to Lunai Bioworks Inc. in August 2025. Lunai Bioworks Inc. is headquartered in Los Angeles, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 9.02M |
| Enterprise Value | 11.28M | Income | -125.52M | Sales | — |
| Book/sh | -0.56 | Cash/sh | 0.02 | Dividend Yield | — |
| Payout | 0.00% | Employees | 29 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | -0.67 | P/C | — |
| EV/EBITDA | -0.91 | EV/Sales | — | Quick Ratio | 0.03 |
| Current Ratio | 0.03 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -7.56 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2026-05-14 | ROA | -13.32% |
| ROE | -3.66% | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 24.19M |
| Shs Float | 14.71M | Short Float | 14.81% | Short Ratio | 1.66 |
| Short Interest | — | 52W High | 5.50 | 52W Low | 0.15 |
| Beta | 0.49 | Avg Volume | 16.16M | Volume | 1.09M |
| Target Price | — | Recom | None | Prev Close | $0.41 |
| Price | $0.37 | Change | -9.47% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
- Lunai Bioworks (LNAI) jumps 189% as traders refocus on recent IP update and looming Nasdaq listing decision - Quiver Quantitative ue, 17 Mar 2026 07
- LNAI Apr 2026 0.500 put (LNAI1260417P00000500) Interactive Stock Chart - Yahoo! Finance Canada Sat, 04 Apr 2026 12
- Why Is Lunai Bioworks Stock (LNAI) Rallying Today? - TipRanks ue, 17 Mar 2026 07
- Lunai Bioworks (NASDAQ: LNAI) asks shareholders to approve up to 1‑for‑30 reverse split - Stock Titan hu, 02 Apr 2026 21
- Why Did LNAI Stock Surge Over 25% Today? - Stocktwits hu, 26 Mar 2026 08
- Why did LNAI stock skyrocket over 130% pre-market today? - MSN Fri, 27 Mar 2026 01
- symbol__ Stock Quote Price and Forecast - cnn.com hu, 02 Oct 2025 14
- LNAI Stock Chart | LUNAI BIOWORKS INC (NASDAQ:LNAI) - ChartMill Fri, 27 Mar 2026 07
- LNAI stock: Lunai Bioworks (NASDAQ) $0.52, vol 509,735,274 on 17 Mar 2026: monitor AI oncology signals - Meyka ue, 17 Mar 2026 07
- What's Behind The Jump In Lunai Bioworks Stock? - Sahm hu, 26 Mar 2026 07
- AI Life Sciences Stock Lunai Bioworks (NASDAQ: LNAI) Makes Nasdaq Top Gainer List on News - Investorideas.com hu, 26 Mar 2026 16
- LNAI Stock Price and Chart — NASDAQ:LNAI - TradingView Wed, 01 Oct 2025 13
- Lunai Bioworks (NASDAQ: LNAI) secures $20M CNS Alzheimer’s deal and converts secured debt - Stock Titan Mon, 30 Mar 2026 21
- Why Is This Micro-Cap Biotech Stock Up 150% Today? - Stocktwits ue, 17 Mar 2026 17
- LNAI Apr 2026 0.500 put (LNAI1260417P00000500) stock price, news, quote and history - Yahoo Finance Singapore Sat, 04 Apr 2026 02
Insider Transactions
Financials
| Line Item | Trend | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Gross Profit |
|
—
|
0.00
|
0.00
|
—
|
| Operating Expense |
|
18.55
-32.28%
|
27.39
+39.76%
|
19.60
-14.15%
|
22.83
|
| Research And Development |
|
0.54
-80.16%
|
2.71
-34.97%
|
4.17
-50.25%
|
8.37
|
| Selling General And Administration |
|
17.88
-27.19%
|
24.56
+60.32%
|
15.32
+6.90%
|
14.33
|
| General And Administrative Expense |
|
17.88
-27.19%
|
24.56
+60.32%
|
15.32
+6.90%
|
14.33
|
| Other Gand A |
|
17.88
-27.19%
|
24.56
+60.32%
|
15.32
+6.90%
|
14.33
|
| Total Expenses |
|
18.55
-32.28%
|
27.39
+39.76%
|
19.60
-14.15%
|
22.83
|
| Operating Income |
|
-18.55
+32.28%
|
-27.39
-39.76%
|
-19.60
+14.15%
|
-22.83
|
| Total Operating Income As Reported |
|
-188.97
-131.46%
|
-81.64
-111.74%
|
-38.56
+66.78%
|
-116.08
|
| EBITDA |
|
-177.15
-106.31%
|
-85.87
-120.95%
|
-38.86
+65.59%
|
-112.94
|
| Normalized EBITDA |
|
-18.30
+32.88%
|
-27.27
-39.95%
|
-19.48
+13.72%
|
-22.58
|
| Reconciled Depreciation |
|
0.13
+5.94%
|
0.12
+7.37%
|
0.11
-8.17%
|
0.12
|
| EBIT |
|
-177.28
-106.16%
|
-85.99
-120.62%
|
-38.98
+65.53%
|
-113.06
|
| Total Unusual Items |
|
-158.85
-171.07%
|
-58.60
-202.38%
|
-19.38
+78.55%
|
-90.36
|
| Total Unusual Items Excluding Goodwill |
|
-158.85
-171.07%
|
-58.60
-202.38%
|
-19.38
+78.55%
|
-90.36
|
| Special Income Charges |
|
-158.74
-170.87%
|
-58.60
-202.40%
|
-19.38
+78.55%
|
-90.36
|
| Other Special Charges |
|
—
|
1.30
|
—
|
—
|
| Impairment Of Capital Assets |
|
170.42
+214.13%
|
54.25
+186.13%
|
18.96
-79.67%
|
93.25
|
| Restructuring And Mergern Acquisition |
|
-11.68
-483.18%
|
3.05
+627.17%
|
0.42
+114.47%
|
-2.90
|
| Net Income |
|
-178.01
-101.31%
|
-88.43
-122.82%
|
-39.68
+65.02%
|
-113.43
|
| Pretax Income |
|
-178.01
-101.31%
|
-88.43
-122.82%
|
-39.68
+65.02%
|
-113.43
|
| Net Non Operating Interest Income Expense |
|
-0.61
+74.97%
|
-2.43
-244.40%
|
-0.71
-181.88%
|
-0.25
|
| Interest Expense Non Operating |
|
0.73
-70.19%
|
2.43
+244.40%
|
0.71
+89.61%
|
0.37
|
| Net Interest Income |
|
-0.61
+74.97%
|
-2.43
-244.40%
|
-0.71
-181.88%
|
-0.25
|
| Interest Expense |
|
0.73
-70.19%
|
2.43
+244.40%
|
0.71
+89.61%
|
0.37
|
| Interest Income Non Operating |
|
0.12
|
—
|
—
|
0.12
|
| Interest Income |
|
0.12
|
—
|
—
|
0.12
|
| Other Income Expense |
|
-158.85
-171.07%
|
-58.60
-202.38%
|
-19.38
+78.55%
|
-90.36
|
| Gain On Sale Of Security |
|
-0.11
|
—
|
-0.00
-11422.22%
|
0.00
|
| Tax Provision |
|
—
|
—
|
0.00
-100.00%
|
0.00
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
-100.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
+100.00%
|
-18.97
|
| Net Income Including Noncontrolling Interests |
|
-178.01
-101.31%
|
-88.43
-122.82%
|
-39.68
+65.02%
|
-113.43
|
| Net Income From Continuing Operation Net Minority Interest |
|
-178.01
-101.31%
|
-88.43
-122.82%
|
-39.68
+65.02%
|
-113.43
|
| Net Income From Continuing And Discontinued Operation |
|
-178.01
-101.31%
|
-88.43
-122.82%
|
-39.68
+65.02%
|
-113.43
|
| Net Income Continuous Operations |
|
-178.01
-101.31%
|
-88.43
-122.82%
|
-39.68
+65.02%
|
-113.43
|
| Normalized Income |
|
-19.16
+35.77%
|
-29.82
-46.88%
|
-20.30
+51.72%
|
-42.05
|
| Net Income Common Stockholders |
|
-178.01
-101.31%
|
-88.43
-122.82%
|
-39.68
+65.02%
|
-113.43
|
| Diluted EPS |
|
-10.80
-18.68%
|
-9.10
-28.17%
|
-7.10
+67.13%
|
-21.60
|
| Basic EPS |
|
-10.80
-18.68%
|
-9.10
-28.17%
|
-7.10
+67.13%
|
-21.60
|
| Basic Average Shares |
|
16.51
+69.27%
|
9.75
+73.31%
|
5.63
+7.11%
|
5.25
|
| Diluted Average Shares |
|
16.51
+69.27%
|
9.75
+73.31%
|
5.63
+7.11%
|
5.25
|
| Diluted NI Availto Com Stockholders |
|
-178.01
-101.31%
|
-88.43
-122.82%
|
-39.68
+65.02%
|
-113.43
|
| Depreciation Amortization Depletion Income Statement |
|
0.13
+5.94%
|
0.12
+7.37%
|
0.11
-8.17%
|
0.12
|
| Depreciation And Amortization In Income Statement |
|
0.13
+5.94%
|
0.12
+7.37%
|
0.11
-8.17%
|
0.12
|
| Line Item | Trend | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Total Assets |
|
8.23
-94.95%
|
163.13
+179.81%
|
58.30
-31.11%
|
84.63
|
| Current Assets |
|
1.05
-47.61%
|
2.00
-22.13%
|
2.57
-73.18%
|
9.57
|
| Cash Cash Equivalents And Short Term Investments |
|
0.48
+117.97%
|
0.22
-88.24%
|
1.87
-79.56%
|
9.17
|
| Cash And Cash Equivalents |
|
0.09
-57.95%
|
0.22
-88.24%
|
1.87
-79.56%
|
9.17
|
| Cash Financial |
|
0.09
-57.95%
|
0.22
-88.24%
|
1.87
-79.56%
|
9.17
|
| Other Short Term Investments |
|
0.39
|
0.00
|
—
|
—
|
| Receivables |
|
0.00
-100.00%
|
1.11
|
0.00
|
—
|
| Other Receivables |
|
—
|
1.11
|
—
|
—
|
| Prepaid Assets |
|
—
|
—
|
—
|
—
|
| Other Current Assets |
|
0.57
-15.38%
|
0.67
-3.18%
|
0.69
+75.81%
|
0.39
|
| Total Non Current Assets |
|
7.18
-95.54%
|
161.13
+189.10%
|
55.74
-25.75%
|
75.07
|
| Net PPE |
|
1.06
-39.76%
|
1.75
+23.11%
|
1.42
-18.39%
|
1.74
|
| Gross PPE |
|
1.76
-24.58%
|
2.33
+23.43%
|
1.89
-10.15%
|
2.10
|
| Accumulated Depreciation |
|
-0.70
-21.41%
|
-0.58
-24.43%
|
-0.46
-30.02%
|
-0.36
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
0.21
+4.88%
|
0.20
+13.29%
|
0.17
+0.00%
|
0.17
|
| Other Properties |
|
1.33
-30.49%
|
1.91
+28.14%
|
1.49
-12.52%
|
1.70
|
| Leases |
|
0.22
+0.00%
|
0.22
+0.00%
|
0.22
+0.00%
|
0.22
|
| Goodwill And Other Intangible Assets |
|
6.13
-96.15%
|
159.36
+193.53%
|
54.29
-25.89%
|
73.26
|
| Goodwill |
|
5.96
-96.26%
|
159.33
+1268.82%
|
11.64
+0.00%
|
11.64
|
| Other Intangible Assets |
|
0.17
+452.52%
|
0.03
-99.93%
|
42.65
-30.78%
|
61.62
|
| Non Current Prepaid Assets |
|
0.00
-100.00%
|
0.02
|
—
|
—
|
| Other Non Current Assets |
|
—
|
0.02
-8.70%
|
0.02
-68.32%
|
0.07
|
| Total Liabilities Net Minority Interest |
|
29.58
-5.04%
|
31.15
+164.03%
|
11.80
-1.79%
|
12.01
|
| Current Liabilities |
|
29.16
-3.81%
|
30.31
+174.97%
|
11.02
+70.88%
|
6.45
|
| Payables And Accrued Expenses |
|
18.40
+24.65%
|
14.76
+145.18%
|
6.02
+147.40%
|
2.43
|
| Payables |
|
12.56
+32.88%
|
9.45
+78.38%
|
5.30
+277.84%
|
1.40
|
| Accounts Payable |
|
12.56
+32.88%
|
9.45
+78.38%
|
5.30
+277.84%
|
1.40
|
| Current Accrued Expenses |
|
5.84
+10.01%
|
5.31
+634.45%
|
0.72
-29.89%
|
1.03
|
| Current Debt And Capital Lease Obligation |
|
9.75
+231.08%
|
2.94
-38.89%
|
4.82
+231.47%
|
1.45
|
| Current Debt |
|
9.44
+284.98%
|
2.45
-47.00%
|
4.62
+285.41%
|
1.20
|
| Other Current Borrowings |
|
0.24
+0.00%
|
0.24
|
—
|
1.20
|
| Current Capital Lease Obligation |
|
0.31
-36.57%
|
0.49
+155.17%
|
0.19
-23.74%
|
0.25
|
| Other Current Liabilities |
|
1.01
-92.00%
|
12.61
+6723.56%
|
0.18
-92.80%
|
2.56
|
| Total Non Current Liabilities Net Minority Interest |
|
0.42
-49.60%
|
0.84
+8.61%
|
0.78
-86.06%
|
5.56
|
| Long Term Debt And Capital Lease Obligation |
|
0.42
-49.60%
|
0.84
+8.61%
|
0.78
-86.06%
|
5.56
|
| Long Term Debt |
|
—
|
—
|
—
|
4.58
|
| Long Term Capital Lease Obligation |
|
0.42
-49.60%
|
0.84
+8.61%
|
0.78
-21.32%
|
0.99
|
| Other Non Current Liabilities |
|
—
|
—
|
—
|
—
|
| Stockholders Equity |
|
-21.35
-116.18%
|
131.98
+183.81%
|
46.50
-35.96%
|
72.62
|
| Common Stock Equity |
|
-21.35
-116.18%
|
131.98
+183.81%
|
46.50
-35.96%
|
72.62
|
| Capital Stock |
|
0.02
+11.95%
|
0.02
+148.74%
|
0.01
+20.16%
|
0.01
|
| Common Stock |
|
0.02
+11.95%
|
0.02
+148.74%
|
0.01
+20.16%
|
0.01
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
17.74
+14.43%
|
15.50
+143.38%
|
6.37
+20.17%
|
5.30
|
| Ordinary Shares Number |
|
17.74
+14.43%
|
15.50
+143.38%
|
6.37
+20.17%
|
5.30
|
| Additional Paid In Capital |
|
478.28
+2.95%
|
464.59
+59.90%
|
290.55
+4.90%
|
276.99
|
| Retained Earnings |
|
-510.46
-53.54%
|
-332.46
-36.24%
|
-244.03
-19.42%
|
-204.35
|
| Gains Losses Not Affecting Retained Earnings |
|
10.81
+6430.17%
|
-0.17
-471.74%
|
-0.03
+1.82%
|
-0.03
|
| Other Equity Adjustments |
|
10.81
+6430.17%
|
-0.17
-471.74%
|
-0.03
+1.82%
|
-0.03
|
| Total Equity Gross Minority Interest |
|
-21.35
-116.18%
|
131.98
+183.81%
|
46.50
-35.96%
|
72.62
|
| Total Capitalization |
|
-21.35
-116.18%
|
131.98
+183.81%
|
46.50
-39.76%
|
77.20
|
| Working Capital |
|
-28.11
+0.72%
|
-28.31
-234.75%
|
-8.46
-371.59%
|
3.11
|
| Invested Capital |
|
-11.91
-108.86%
|
134.43
+162.93%
|
51.13
-34.78%
|
78.40
|
| Total Debt |
|
10.17
+168.65%
|
3.79
-32.30%
|
5.59
-20.27%
|
7.02
|
| Net Debt |
|
9.34
+318.88%
|
2.23
-18.90%
|
2.75
|
—
|
| Capital Lease Obligations |
|
0.74
-44.79%
|
1.34
+37.87%
|
0.97
-21.81%
|
1.24
|
| Net Tangible Assets |
|
-27.48
-0.35%
|
-27.38
-251.58%
|
-7.79
-1123.81%
|
-0.64
|
| Tangible Book Value |
|
-27.48
-0.35%
|
-27.38
-251.58%
|
-7.79
-1123.81%
|
-0.64
|
| Current Notes Payable |
|
9.19
+316.63%
|
2.21
-52.30%
|
4.62
|
0.00
|
| Line Item | Trend | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-7.87
+28.23%
|
-10.97
+6.82%
|
-11.77
+25.16%
|
-15.73
|
| Cash Flow From Continuing Operating Activities |
|
-7.87
+28.23%
|
-10.97
+6.82%
|
-11.77
+25.16%
|
-15.73
|
| Net Income From Continuing Operations |
|
-178.01
-101.31%
|
-88.43
-122.82%
|
-39.68
+65.02%
|
-113.43
|
| Depreciation Amortization Depletion |
|
0.13
+5.94%
|
0.12
+7.37%
|
0.11
-8.17%
|
0.12
|
| Depreciation |
|
0.12
+4.96%
|
0.11
+5.82%
|
0.11
-1.17%
|
0.11
|
| Amortization Cash Flow |
|
0.01
+19.36%
|
0.01
+34.35%
|
0.01
-58.82%
|
0.01
|
| Depreciation And Amortization |
|
0.13
+5.94%
|
0.12
+7.37%
|
0.11
-8.17%
|
0.12
|
| Amortization Of Intangibles |
|
0.01
+19.36%
|
0.01
+34.35%
|
0.01
-58.82%
|
0.01
|
| Other Non Cash Items |
|
-9.70
-216.98%
|
8.29
+732.79%
|
1.00
+138.31%
|
-2.60
|
| Stock Based Compensation |
|
3.31
-29.10%
|
4.67
+32.19%
|
3.54
-35.62%
|
5.49
|
| Asset Impairment Charge |
|
170.42
+214.13%
|
54.25
+186.13%
|
18.96
-79.67%
|
93.25
|
| Operating Gains Losses |
|
—
|
1.30
|
—
|
0.02
|
| Unrealized Gain Loss On Investment Securities |
|
0.11
|
0.00
|
—
|
—
|
| Gain Loss On Sale Of PPE |
|
—
|
—
|
0.00
-100.00%
|
0.02
|
| Change In Working Capital |
|
5.86
-33.50%
|
8.81
+104.68%
|
4.31
+204.23%
|
1.42
|
| Change In Receivables |
|
1.15
+204.11%
|
-1.11
-2409332.61%
|
0.00
-97.11%
|
0.00
|
| Change In Prepaid Assets |
|
1.14
+5.64%
|
1.08
+1.12%
|
1.07
+132.00%
|
0.46
|
| Change In Payables And Accrued Expense |
|
3.61
-59.15%
|
8.83
+166.17%
|
3.32
+252.16%
|
0.94
|
| Change In Accrued Expense |
|
0.50
-89.53%
|
4.77
+923.98%
|
-0.58
-314.50%
|
-0.14
|
| Change In Payable |
|
3.11
-23.44%
|
4.06
+4.17%
|
3.89
+260.21%
|
1.08
|
| Change In Account Payable |
|
3.11
-23.44%
|
4.06
+4.17%
|
3.89
+260.21%
|
1.08
|
| Change In Other Current Liabilities |
|
-0.04
-477.20%
|
0.01
+113.88%
|
-0.08
-871.20%
|
0.01
|
| Investing Cash Flow |
|
-0.50
+60.32%
|
-1.26
-4132.48%
|
-0.03
-477.46%
|
-0.01
|
| Cash Flow From Continuing Investing Activities |
|
-0.50
+60.32%
|
-1.26
-4132.48%
|
-0.03
-477.46%
|
-0.01
|
| Net PPE Purchase And Sale |
|
0.00
+100.00%
|
-0.07
-136.55%
|
-0.03
-477.46%
|
-0.01
|
| Purchase Of PPE |
|
0.00
+100.00%
|
-0.07
-136.55%
|
-0.03
-477.46%
|
-0.01
|
| Capital Expenditure |
|
—
|
-0.07
-136.55%
|
-0.03
-477.46%
|
-0.01
|
| Net Investment Purchase And Sale |
|
-0.50
|
0.00
|
—
|
—
|
| Purchase Of Investment |
|
-0.50
|
0.00
|
—
|
—
|
| Net Business Purchase And Sale |
|
0.00
+100.00%
|
-1.19
|
0.00
|
—
|
| Purchase Of Business |
|
0.00
+100.00%
|
-1.26
|
0.00
|
—
|
| Financing Cash Flow |
|
8.38
-20.30%
|
10.52
+132.94%
|
4.52
+6.23%
|
4.25
|
| Cash Flow From Continuing Financing Activities |
|
8.38
-20.30%
|
10.52
+132.94%
|
4.52
+6.23%
|
4.25
|
| Net Issuance Payments Of Debt |
|
6.98
-13.27%
|
8.05
|
0.00
+100.00%
|
-0.56
|
| Issuance Of Debt |
|
6.98
-13.27%
|
8.05
|
0.00
|
—
|
| Repayment Of Debt |
|
—
|
-0.87
+22.44%
|
-1.12
-100.01%
|
-0.56
|
| Long Term Debt Issuance |
|
6.98
-13.27%
|
8.05
|
0.00
|
—
|
| Long Term Debt Payments |
|
—
|
-0.87
+22.44%
|
-1.12
-100.01%
|
-0.56
|
| Net Long Term Debt Issuance |
|
6.98
-13.27%
|
8.05
|
0.00
+100.00%
|
-0.56
|
| Short Term Debt Issuance |
|
—
|
4.28
|
0.00
|
—
|
| Net Short Term Debt Issuance |
|
—
|
4.28
|
0.00
|
—
|
| Net Common Stock Issuance |
|
2.38
-20.79%
|
3.00
-25.22%
|
4.01
-14.21%
|
4.68
|
| Proceeds From Stock Option Exercised |
|
0.00
-100.00%
|
0.34
-78.96%
|
1.62
+1104.48%
|
0.13
|
| Net Other Financing Charges |
|
-0.97
-11.63%
|
-0.87
+22.44%
|
-1.12
-100.01%
|
-0.56
|
| Changes In Cash |
|
0.01
+100.47%
|
-1.71
+76.48%
|
-7.29
+36.54%
|
-11.49
|
| Effect Of Exchange Rate Changes |
|
-0.14
-325.96%
|
0.06
+816.39%
|
-0.01
-60.21%
|
-0.01
|
| Beginning Cash Position |
|
0.22
-88.24%
|
1.87
-79.56%
|
9.17
-55.61%
|
20.66
|
| End Cash Position |
|
0.09
-57.95%
|
0.22
-88.24%
|
1.87
-79.56%
|
9.17
|
| Free Cash Flow |
|
-7.87
+28.68%
|
-11.04
+6.46%
|
-11.80
+24.99%
|
-15.74
|
| Interest Paid Supplemental Data |
|
0.02
+21.99%
|
0.02
-94.29%
|
0.35
+341.99%
|
0.08
|
| Income Tax Paid Supplemental Data |
|
0.00
|
0.00
|
0.00
-100.00%
|
0.00
|
| Common Stock Issuance |
|
2.38
-20.79%
|
3.00
-25.22%
|
4.01
-14.21%
|
4.68
|
| Issuance Of Capital Stock |
|
2.38
-20.79%
|
3.00
-25.22%
|
4.01
-14.21%
|
4.68
|
| Sale Of Business |
|
0.00
-100.00%
|
0.07
|
0.00
|
—
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-03-30 View
- 8-K2026-03-05 View
- 8-K2026-02-23 View
- 10-Q2026-02-17 View
- 8-K2026-02-12 View
- 8-K2025-12-03 View
- 8-K2025-11-25 View
- 10-Q2025-11-14 View
- 8-K2025-11-06 View
- 8-K2025-11-03 View
- 8-K2025-10-30 View
- 8-K2025-10-16 View
- 10-K2025-09-29 View
- 8-K2025-09-24 View
- 8-K2025-09-05 View
- 8-K2025-08-26 View
- 8-K2025-08-06 View
- 8-K2025-07-25 View
- 8-K2025-07-14 View
- 8-K2025-07-09 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|